PharmaNet Development Group, Inc. (PDGI) Stock Explodes after Company Agrees to be Acquired by JLL Partners
Today, PharmaNet Development Group, Inc. announced that it has entered into a definitive merger agreement with affiliates of JLL Partners, Inc. ('JLL'). As terms of the agreement, JLL will commence a tender offer to purchase all of the outstanding shares of PharmaNet at a price of $5.00 per share in cash, an approximate 373% premium to yesterday’s closing price. Although PharmaNet’s Board of Directors has approved the definitive merger agreement, the transaction is subject to the valid tender of a majority of PharmaNet common stock, regulatory approvals and other customary conditions. However, it is not subject to any financing conditions.…